Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Neurosurg ; 49(2): 81-5, 2013.
Article in English | MEDLINE | ID: mdl-24435068

ABSTRACT

INTRODUCTION: Bevacizumab has been reported to effectively reduce cerebral edema caused by radiation therapy. However, only limited data with a short follow-up in tumor patients are available so far. PATIENTS AND METHODS: Two children suffering from hemorrhage from arteriovenous malformation (AVM) have been treated with stereotactic radiotherapy and developed radiation-induced cerebral edema with deteriorating neurological status despite maximized steroid therapy. Bevacizumab administration at 5 mg/kg body weight was initiated every 2 weeks. RESULTS: Bevacizumab treatment rapidly ameliorated the neurological deficits, malignant edema and prevented catastrophic complications. Corticoid therapy could be reduced and discontinued. However, after 18 months, both patients showed identical or worse neurological status than before bevacizumab therapy. AVM radiation therapy had been successful to completely obliterate AVMs. DISCUSSION: In our limited experience, bevacizumab may be an effective and safe option for rescue therapy for malignant cerebral edema on the basis of radiation-induced necrosis especially in patients who experience rapid deterioration despite corticoid therapy and/or intolerable steroid side effects. Despite the fact that functional improvement could not be achieved in long-term outcome patients significantly stabilized and improved during periods of acute deterioration. In order to determine the long-term effectiveness of bevacizumab further investigation in placebo-controlled studies with a higher number of patients are required.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Brain Edema/drug therapy , Brain Edema/etiology , Intracranial Arteriovenous Malformations/radiotherapy , Radiation Injuries/drug therapy , Bevacizumab , Brain Edema/diagnosis , Child , Female , Humans , Intracranial Arteriovenous Malformations/diagnosis , Male , Necrosis/diagnosis , Necrosis/drug therapy , Necrosis/etiology , Radiation Injuries/diagnosis , Treatment Outcome
2.
Acta Oncol ; 45(7): 881-9, 2006.
Article in English | MEDLINE | ID: mdl-16982554

ABSTRACT

To evaluate our initial experience with image guided respiratory gated H-SBRT for liver and lung tumors. The system combines a stereoscopic x-ray imaging system (ExacTrac X-Ray 6D) with a dedicated conformal stereotactic radiosurgery and radiotherapy linear accelerator (Novalis) and ExacTrac Adaptive Gating for dynamic adaptive treatment. Moving targets are located and tracked by x-ray imaging of implanted fiducial markers defined in the treatment planning computed tomography (CT). The marker position is compared with the position in verification stereoscopic x-ray images, using fully automated marker detection software. The required shift for a correct, gated set-up is calculated and automatically applied. We present our acceptance testing and initial experience in patients with liver and lung tumors. For treatment planning CT and Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) as well as magnetic resonance imaging (MRI) taken at free breathing and expiration breath hold with internal and external fiducials present were used. Patients were treated with 8-11 consecutive fractions to a dose of 74.8-79.2 Gy. Phantom tests demonstrated targeting accuracy with a moving target to within +/-1 mm. Inter- and intrafractional patient set-up displacements, as corrected by the gated set-up and not detectable by a conventional set-up, were up to 30 mm. Verification imaging to determine target location during treatment showed an average marker position deviation from the expected position of up to 4 mm on real patients. This initial evaluation shows the accuracy of the system and feasibility of image guided real-time respiratory gated H-SBRT for liver and lung tumors.


Subject(s)
Carcinoma/surgery , Liver Neoplasms/surgery , Lung Neoplasms/surgery , Radiosurgery/methods , Respiration , Surgery, Computer-Assisted/methods , Aged , Dose Fractionation, Radiation , Female , Humans , Male , Middle Aged , Movement/physiology , Phantoms, Imaging , Radiosurgery/instrumentation
3.
Int J Radiat Oncol Biol Phys ; 49(5): 1451-60, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-11286853

ABSTRACT

PURPOSE: Conformal stereotactic radiosurgery and radiotherapy using a linear accelerator and a micromultileaf collimator (mMLC) offer the possibility of irradiating irregularly shaped target volumes. Dynamic arc radiosurgery and radiotherapy, i.e., stereotactic radiation therapy combining a moving gantry with a dynamic mMLC, enable the radiation even of lesions with concave structures. METHODS AND MATERIALS: The dynamic arc method requires additional tools for quality assurance (QA) and three-dimensional verification at a high spatial resolution. A QA program was developed. Dose distributions of planning target volumes with concavities were investigated in polymer gel phantoms. The radiation-induced change of the relaxation rate R(2) was measured by magnetic resonance imaging. The distributions were compared with image processing tools. RESULTS: Using the therapy-planning software BrainSCAN 4.0 (and 4.1 beta) in combination with the mMLC m3, deviations between the planned and measured 90% isodoses of about 2 mm were registered in the isocenter plane. Three-dimensional verification was feasible in the range of accuracy achieved in planning and dose measurement. CONCLUSIONS: Dynamic arc radiosurgery and radiotherapy offer excellent conformation even for complicated planning target volumes with concavities. The dose distribution calculated with the treatment-planning software used can be accomplished with the available equipment. Patients can be treated by dynamic arc radiosurgery and radiotherapy.


Subject(s)
Phantoms, Imaging , Radiosurgery/methods , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods , Calibration , Combined Modality Therapy , Humans , Magnetic Resonance Imaging , Particle Accelerators , Physical Phenomena , Physics , Quality Control , Radiosurgery/instrumentation , Radiosurgery/standards , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/instrumentation , Radiotherapy Planning, Computer-Assisted/standards , Radiotherapy, Conformal/instrumentation , Radiotherapy, Conformal/standards
5.
Oncogene ; 18(37): 5148-58, 1999 Sep 16.
Article in English | MEDLINE | ID: mdl-10498864

ABSTRACT

It has been repeatedly suspected that telomere shortening might be one possible trigger of the p53-dependent cell cycle arrest, although the mechanism of this arrest remained unclear. Telomeres in human cells under mild oxidative stress accumulate single-strand damage faster than interstitial repetitive sequences. In MRC-5 fibroblasts and U87 glioblastoma cells, which both express wild-type p53, oxidative stress-mediated production of single-strand damage in telomeres is concomitant to the accumulation of p53 and p21 and to cell cycle arrest. This response can be modeled by treatment of cells with short single stranded telomeric G-rich DNA fragments. The arrest is transient in U87 cells. Recovery from it is accompanied by up-regulation of telomerase activity and elongation of telomeres. Overexpression of mutated p53 is sufficient to reverse the phenotype of inhibition as well as the delayed activation of telomerase. These data suggest that the production of G-rich single stranded fragments during the course of telomere shortening is sufficient to trigger a p53 dependent cell cycle arrest.


Subject(s)
Cell Cycle/physiology , DNA Fragmentation , DNA, Single-Stranded/metabolism , Telomere/ultrastructure , Tumor Suppressor Protein p53/physiology , Adenocarcinoma/pathology , Amino Acid Substitution , Brain Neoplasms/pathology , Breast Neoplasms/pathology , Cell Line, Transformed , Female , Fibroblasts/physiology , Genes, p53 , Glioblastoma/pathology , Guanine/analysis , Humans , Lung/cytology , Neoplasm Proteins/physiology , Ovarian Neoplasms/pathology , Oxidative Stress , Point Mutation , Recombinant Fusion Proteins/physiology , Telomerase/physiology , Telomere/chemistry , Tumor Cells, Cultured
6.
Radiother Oncol ; 50(3): 325-36, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10392819

ABSTRACT

PURPOSE: A computer controlled micro multi-leaf collimator, m3 mMLC, has been commissioned for conformal, fixed-field radiosurgery applications. Measurements were made to characterise the basic dosimetric properties of the m3, such as leaf transmission, leakage and beam penumbra. In addition, the geometric and dosimetric accuracy of the m3 was verified when used in conjunction with a BrainSCAN v3.5 stereotactic planning system. MATERIALS AND METHODS: The m3 was detachably mounted to a Varian Clinac 2100C accelerator delivering 6 MV X-rays. Leaf transmission, leakage, penumbra and multiple, conformal fixed field dose distributions were measured using calibrated film in solid water. Beam data were collected using a diamond detector in a scanning water tank and planned dose distributions were verified using LiF TLDs and film. A small, shaped phantom was also constructed to confirm field shaping accuracy using portal images. RESULTS: Mean transmission through the closed multi-leaves was 1.9 +/- 0.1% and leakage between leaves was 2.8 +/- 0.15%. Between opposing leaves abutting along the central beam-axis transmission was approximately 15 +/- 3%, but was reduced to a mean of 4.5 +/- 0.6% by moving the abutmen position 4.5 cm off-axis. Beam penumbrae were effectively constant as a function of increasing square field size and asymmetric fields and was seen to vary non-linearly when shaped to diagonal, straight edges. TMR, OAR and relative output beam data measurements of circular m3 fields were comparable to conventional, circular stereotactic collimators. Multiple, conformal field dose distributions were calculated with good spatial and dosimetric accuracy, with the planned 90% isodose curves agreeing with measurements to within 1-2 mm and to +/- 3% at isocentre. Portal films agreed with planned beams eye-view field shaping to within 1 mm. CONCLUSIONS: The m3 micro multi-leaf collimator is a stable, high precision field-shaping device suitable for small-field, radiosurgery applications. Dose distributions can be accurately calculated by a planning system using only a few beam data parameters.


Subject(s)
Radiosurgery/methods , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods , Brain/surgery , Densitometry , Humans , Particle Accelerators , Phantoms, Imaging , Quality Assurance, Health Care , Radiometry , Radiosurgery/instrumentation , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/instrumentation , Radiotherapy, Conformal/instrumentation , Stereotaxic Techniques , Thermoluminescent Dosimetry/methods , X-Ray Film
SELECTION OF CITATIONS
SEARCH DETAIL
...